Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2026-06-11 Regulatory Filings
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
Preclinical data posters presented at EHA Congress
Regulatory Filings Classification · 6% confidence The document is an RNS regulatory announcement (RNS Number: 8482H) from Poolbeg Pharma plc describing the presentation of two scientific posters at a conference. It is a press release distributed via the London Stock Exchange’s Regulatory News Service and does not contain financial results, board changes, dividend notices, or any formal report filings. It is an RNS announcement of new research, falling under the general Regulatory Filings category.
2026-06-11 English
Poolbeg Announces POLB 001 TOPICAL Site Activation
Regulatory Filings Classification · 12% confidence The document is an RNS news release from Poolbeg Pharma announcing a clinical trial operational milestone (site activation). It does not contain financial statements, earnings data, board changes, share transactions, or other specific events. It is a general regulatory announcement of corporate news, fitting the fallback category for miscellaneous regulatory filings.
2026-06-11 Latin
Results of AGM & Change of Registered Address
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an RNS regulatory announcement of the Company’s Annual General Meeting results, explicitly noting that all resolutions were duly passed and indicating that voting results will be published shortly. It also mentions a change of registered address but the primary subject is the declaration of AGM voting results. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-06-09 English
Group of companies' accounts made up to 2025-12-31
Annual Report Classification · 95% confidence The document is titled “Annual Report & Accounts 2025” and contains a Strategic Report, Corporate Governance section, Independent Auditor’s Report, full financial statements (income, balance sheet, cash flows, notes), and directors’ reports. It is the official yearly report covering the company’s activities and full financial performance for the fiscal year ended 31 December 2025. Accordingly, it matches the definition of an Annual Report (Code 10-K). FY 2025
2026-05-29 English
Pre-IND Meeting with the FDA for POLB 001
Regulatory Filings Classification · 90% confidence The document is a press release via the London Stock Exchange’s RNS system announcing the outcome of a pre-IND meeting with the FDA. It contains no financial statements, voting results, management changes, or other specific report content. It is a standard regulatory news announcement, fitting the “Regulatory Filings” (RNS) fallback category.
2026-05-26 English
POLB 001 poster to be presented at EHA 2026
Regulatory Filings Classification · 90% confidence The document is an RNS press release announcing Poolbeg Pharma’s presentation of a scientific poster at a medical congress (EHA 2026). It does not contain financial results, regulatory certifications, management changes, dividends, or detailed report data. It is a general regulatory announcement distributed via RNS and thus falls under the fallback category for miscellaneous regulatory filings.
2026-05-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.